Your Blood Test Could Change With the Seasons

Gloved hand holding blood vial over colorful test tubes — Photo: Jarun Ontakrai / Shutterstock

New evidence shows the timing of a simple blood draw can tip people above or below the anemia line.

Story Snapshot

Studies report hemoglobin runs higher in winter and lower in summer, shifting results near the cutoff.
Large routine-lab datasets also detect seasonal links with hemoglobin in people without known illness.
One analysis found summer hemoglobin dips pushed more women below the “normal” range than in winter.
Other research says seasonal swings rarely justify changing official reference intervals.

What the studies actually found on seasonal swings

Multiple studies across decades report a repeat pattern. Hemoglobin and related red cell measures are higher in winter and lower in summer, across many regions and groups. A meta-analysis of human studies concluded both hemoglobin and hematocrit rise in winter versus summer, confirming a broad trend that lab workers have long suspected. Blood donor screening programs also see this cycle. They have recorded clear seasonal changes in hemoglobin and in the share of donors turned away for low levels.

Routine clinical datasets back this up. A 2024 analysis of people visiting diagnostic labs found a positive association between season and hemoglobin. These were not specialty patients but regular visitors without known illness. The seasonal signal was detectable even after standard data cleaning, which suggests it is a real pattern in everyday testing, not a rare edge case. These findings matter most for people whose results sit near the diagnostic cutoff, where small shifts can change labels.

How timing near the cutoff can change real-world labels

Population data from a United Kingdom pathology program showed modest seasonal movement in average hemoglobin, about two to three grams per liter between the summer low and winter high. That small shift changed how many women fell below the lab’s normal range. In summer, about 20 percent of women’s results were below the reference range, compared with about 18 percent in winter, a difference large enough to alter how many are flagged for follow-up.

Donor centers have felt this at the door. When average hemoglobin dips, more donors fail the screen, even if nothing else has changed. That is a practical sign that timing can push borderline results across a hard line. It also hints at the stakes for clinics that use fixed thresholds to trigger iron studies, imaging, or referrals. A small seasonal nudge may mean a test or a treatment in one month, and a “watch and wait” in another.

Why some experts urge caution on changing protocols

Not all research points to a need for new reference intervals. The 2024 routine-laboratory study found seasonal associations for some measures, including hemoglobin, but reported no significant seasonal effects on the derived reference intervals. In other words, the middle 95 percent band did not shift enough to warrant season-specific cutoffs in that dataset. The authors’ stance supports keeping current intervals while urging awareness of timing effects near the threshold.

This split view reflects a common problem in diagnostics. Biology moves a little; policy prefers fixed lines. For most people, the seasonal change is small and will not flip a clear normal into anemia or the reverse. But for those close to the cutoff, timing can matter. That is why many guidelines already advise repeat testing before major decisions, and why clinicians often pair hemoglobin with ferritin and symptoms to avoid snap calls based on a single draw.

What patients and clinicians can do right now

Patients who sit near the anemia threshold can reduce noise. Schedule repeat labs at the same time of day, and be consistent about posture, hydration, and fasting. If a result is borderline in midsummer, consider a repeat in a few weeks, especially if symptoms do not fit the number. Clinicians can document collection time and season, and confirm low results with ferritin and other iron studies before labeling long-term disease or ordering invasive tests.

Policy leaders can help by supporting audits that quantify how often timing flips results across cutoffs in primary care. Health systems can flag results within a narrow band around the anemia line and nudge repeat testing before major referrals. These steps are low cost and reduce both over-treatment and missed cases. They also fit a broader goal many Americans share: make basic systems work better, with fewer surprises tied to the calendar rather than the patient.